SLC7A11 and neoplasm: We also attempted a similar PRIMA-1Met experiment with an intracranial GBM22 tumor model (Figure S2A); however, we did not achieve a significant reduction in xCT protein (Figure S2B), most likely due to the inability of PRIMA-1Met to penetrate the blood–brain barrier [28].